Revisionist history on healthcare at the VP debate
In the VP debate, Tim Walz and JD Vance were forceful, unexpectedly convivial, and fast and loose with the facts, particularly on healthcare.
Blue Shield of California bypasses PBMs to slash Humira pric...
Blue Shield of California is pioneering a strategy that bypasses traditional pharmacy benefit managers to slash the price of Humira by up to 90%
Amgen to face investor lawsuit over $10.7bn tax liability di...
A federal judge in New York has ruled that Amgen must answer to claims of
FDA issues summary of grants, promotes rare disease research
The US Food and Drug Administration (FDA) has provided an ‘at-a-glance’ summary of the agency’s news.
J&J's 340B rebate scheme stymied by strong-arm HRSA letter
Johnson & Johnson's stand against 340B abuse and duplicate discounts came to a halt in the face of HRSA threats of termination.
Editor's Picks
Editor's Picks
Partner Content
FT Global Pharma & Biotech Summit 2024
The Global Pharma and Biotech Summit is the essential annual event for you to stay on top of the latest trends and innovations in life sciences.
8th Dermatology Drug Development Summit
Industry’s Destination to Discover & Develop Best-In-Class Drugs for Immuno-Inflammatory Skin Disease
7th RNA-Targeted Drug Discovery & Development Summit
Optimizing Lead Discovery, Structural Analysis & Preclinical Modeling to Successfully Develop Stable, Effective & Orally Bioavailable Small Molecule RNA Drugs for Robust Translation
9th CDD For Biologics Summit 2024
Integrate Computational Biology, Generative AI & Machine Learning to Revolutionize Biologics Drug Discovery & Development
Targeted Radiopharmaceuticals Summit EU 2024
Taking place in Amsterdam 3rd- 5th December! With 40+ new speakers, 2 tracks of content (pre-clinical and clinical), a deep dive workshop day